Pioglitazone 15mg
Sponsors
Chong Kun Dang Pharmaceutical, University at Buffalo, Madrigal Pharmaceuticals, Inc., Mansoura University, Boryung Pharmaceutical Co., Ltd
Conditions
Breast CancerCML, Chronic PhaseChronic Myelogenous Leukemia, BCR-ABL PositiveCognitive ImpairmentDrug EffectHealthyHigh AltitudeInflammation
Phase 1
Phase 2
Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment
CompletedNCT04883125
Start: 2018-01-01End: 2021-04-15Updated: 2021-05-12
Pioglitazone Therapy Targeting Fatigue in Breast Cancer
RecruitingNCT05013255
Start: 2021-12-23End: 2026-12-31Target: 30Updated: 2025-04-08
Safety and Suitability of Supplementing Early MIP Surgery (MIPS) of ICH With Pioglitazone
TerminatedNCT05582707
Start: 2023-05-08End: 2024-09-19Updated: 2024-09-23
Early Application of Memantine and Pioglitazone to Protect Cognitive Function After Radiotherapy
Not yet recruitingNCT06594172
Start: 2024-09-10End: 2027-06-30Target: 67Updated: 2024-09-19
Phase 3
Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin
CompletedNCT01106131
Start: 2010-05-31End: 2012-11-30Updated: 2013-02-15
A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
CompletedNCT04885712
Start: 2021-05-28End: 2023-03-10Updated: 2023-05-24
Phase 4
Effect of Pioglitazone on Oxidative Load, Inflammatory End-Points and Vascular Reactivity in Obese Non-Diabetic Patients: A Dose Ranging Study
CompletedNCT01161394
End: 2003-10-31Target: 24Updated: 2022-01-27
Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD
NCT05942963
Start: 2023-10-31End: 2024-04-30Target: 240Updated: 2023-07-12
Effects of Pioglitazone on Exogenous Carbohydrate Oxidation During Steady-State Exercise at High Altitude
CompletedNCT06164665
Start: 2023-03-01End: 2023-07-01Updated: 2026-03-19